“The existing predicament has uncovered some structural weaknesses within the EU’s medicines source chain along with a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides stated. She encouraged that provide chain issues be resolved in an EU pharmaceutical approach anticipated to generally